Pfizer, AstraZeneca Stay Quiet As Cooling-Off Period Ends
A mandatory cooling-off period that prohibited Pfizer Inc. from making a fresh offer for British rival AstraZeneca PLC expired on Tuesday, but neither company showed any movement toward the bargaining table despite...To view the full article, register now.
Already a subscriber? Click here to view full article